Clinical Trials Logo

Neurodermatitis clinical trials

View clinical trials related to Neurodermatitis.

Filter by:

NCT ID: NCT00878670 Completed - Atopic Dermatitis Clinical Trials

Investigation of Efficacy and Safety of EPOGAM

Start date: March 2009
Phase: Phase 4
Study type: Interventional

In this study it will be investigated if patients with atopic dermatitis responding to EPOGAM treatment, show a significant increase of dihomo-gamma-linolic acid in the blood.

NCT ID: NCT00869089 Completed - Prurigo Nodularis Clinical Trials

Safety and Efficacy of CC-10004 for Prurigo Nodularis

Start date: September 2008
Phase: Phase 2
Study type: Interventional

This trial will include: - Study period up to 7 months. - Office visits monthly lasting approximately 1 hour. - Blood Draws. - Oral medication that is taken 2 times daily. - Photographs and biopsies if agreed.

NCT ID: NCT00507832 Completed - Prurigo Nodularis Clinical Trials

Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease

CASM981CDE21
Start date: April 2007
Phase: Phase 2
Study type: Interventional

The development of the topical calcineurin inhibitor pimecrolimus resulted in a significant improvement in the treatment of atopic dermatitis. In addition, an excellent amelioration of pruritus could be regularly observed. Up to now, several itchy dermatoses such as chronic irritative hand dermatitis, rosacea, graft-versus-host-disease, lichen sclerosus, prurigo simplex, scrotal eczema, and inverse psoriasis were reported as single cases also to respond to a pimecrolimus treatment. In prurigo nodularis, pruritus is the main symptom and it is of immediate importance to find an effective antipruritic therapy. Pruritus is regularly severe and therapy refractory to topical steroids or systemic antihistamines. Capsaicin cream is one effective possibility to reduce the itch in these diseases. However, it has to be applied 3 to 6 times daily, rubs off on the clothing and induces burning in erosions. In addition, since no commercial preparation is available, it has to be prescribed in several concentrations. The application of pimecrolimus seems to be promising since it has to be applied twice daily only. Especially in prurigo nodularis we expect a good response as we could demonstrate in single patients. Furthermore it has been published recently that Tacrolimus, another calcineurin inhibitor has been successfully used in the treatment of six patients with prurigo nodularis. This study is designed to compare the efficacy and safety of pimecrolimus 1% cream and hydrocortisone 1% cream in prurigo nodularis and to investigate the mode of action of the antipruritic effect of the drugs.

NCT ID: NCT00196430 Completed - Neurodermatitis Clinical Trials

Study About Effectiveness of Silver-Containing Textiles for Treatment of Acute Neurodermatitis

Start date: January 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate whether the treatment of acute neurodermitis with silver-contained textiles is equivalent or more effective to the conservative exogenous treatment with a corticosteroid. Secondary aim is to define skin comfortability of the textiles.